Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Acquired Localized Cutis Laxa due to Increased Elastin Turnover

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Omalizumab for chronic urticaria: a case series and overview of the literature

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Cutaneous adverse reactions to anti-PD-1 treatment - a systematic review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Natural ingredients in cosmetic products - a suggestion for a screening series for skin allergy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Effect of Anti-interleukin-17 Treatment on Haemoglobin A1c Levels

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Cost of Treating Skin Problems in Patients with Diabetes who Use Insulin Pumps and/or Glucose Sensors

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Dupilumab treatment in two patients with severe allergic contact dermatitis caused by sesquiterpene lactones

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Alopecia areata (AA) is the most common immune-mediated hair loss disorder with a life-time prevalence of 2%. The pathogenesis of AA is not completely understood, but interferon gamma (INF-γ) and Janus kinases (JAK) may play a key role. Here, we present a case involving a male patient with psoriasis and psoriatic arthritis, who exhibited a rapid hair loss, diagnosed as AA, during ciclosporin treatment. As ciclosporin was unable to control his psoriasis, the treatment was changed to methotrexate injections, but the hair loss progressed into alopecia universalis. During treatment with the oral JAK inhibitor tofacitinib, the patient presented an almost complete hair remission on the scalp and partly on the eyebrows, eyelashes, beard, and chest. Furthermore, the patient experienced no joint complaints and his psoriasis was improved. Based on these findings, JAK inhibitors may be an optional treatment in complicated cases involving both rheumatological and dermatological diseases.

OriginalsprogEngelsk
TidsskriftCase Reports in Dermatology
Vol/bind12
Udgave nummer2
Sider (fra-til)150-154
Antal sider5
ISSN1662-6567
DOI
StatusUdgivet - 2 okt. 2020

Bibliografisk note

Copyright © 2020 by S. Karger AG, Basel.

ID: 60995119